Abstract

The majority of HIV / AIDS patients have common secondary infections including of oral candidiasis. Fluconazole can be used to treat oral resistance in candidiasis. Management that can reduce risk can be minimized. However, some evidences suggest that the use of fluconazole is not effective for oral candidiasis. A 34-year-old male patient went to Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, with main complaint of discomfort and pain in the tongue. The physical examination showed a white pseudomembrane on the tongue and palate, which could be removed but left reddish and painful marks. The examination from tongue and palate swab found a colony of white Candida albicans and showed resistant to fluconazole, intermediate to ketoconazole, and sensitive to nystatin. The patient received nystatin oral suspension for three times a day as much as 5 ml (500,000 units). The pseudomembrane disappeared on day 10. The medication continued for fourteen days. No sign of recurrent found in two weeks after the treatment. The administration of nystatin can be used as an effective medication for oral candidiasis.

Highlights

  • Indonesia is a country with high number of HIV/AIDS cases

  • The examination from tongue and palate swab found a colony of white Candida albicans and showed resistant to fluconazole, intermediate to ketoconazole, and sensitive to nystatin

  • We would like to report cases of HIV/AIDS patient with oral candidiasis who were resistant to fluconazole and what treatment we gave as the substitute for fluconazole

Read more

Summary

INTRODUCTION

Indonesia is a country with high number of HIV/AIDS cases. There were 36.7 million HIV/ AIDS patients reported in Indonesia in 2016. We would like to report cases of HIV/AIDS patient with oral candidiasis who were resistant to fluconazole and what treatment we gave as the substitute for fluconazole. Based on the signs symptoms that arise in the patient gets the main diagnosis of oral candidiasis and a second diagnosis was HIV / AIDS stage IV He has potenta urinary tract infection diagnosis and we collaborated with genital division but it was not administered any therapy. Therapy: he received were administration of fluconazole of 150 mg/ day, duviral of 1 tablet/day (300 mg zidovudine and 150 mg lamivudine), multivitamin B complex and iron 1 tablet/day, counseling, educated to oral hygiene, and collaboration giving high-protein high-calorie diets One week later, he wasn’t not feeling better post use of fluconazole so that swab examination from oral tissue was taken. No sign of complications or recurrence was found

Findings
DISCUSSION
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call